Real-World diabetes drug study launches in russia
Disease control
Recruiting now
This study watches 300 adults with type 2 diabetes who are already taking the drug luseogliflozin (Lusefi®) as part of their normal care. Researchers will track changes in blood sugar, weight, and blood pressure over time to see how effective and tolerable the drug is in real-wor…
Sponsor: Servier Russia • Aim: Disease control
Last updated May 26, 2026 10:30 UTC